1-4 of 4
Waldemar Priebe, Ph.D.
Close
Sort by
Journal Articles

Jak2 Phosphorylates Tyr 177 of Bcr-Abl Activating the Ras and PI-3 Kinase Pathways and Maintains Functional Levels of Bcr-Abl in Chronic Myelogenous Leukemia.

Ajoy K. Samanta, PhD, Sandip N. Chakraborty, Xiaoping Sun, M.D., Ph.D, Ellen Schlette, M.D., Waldemar Priebe, Ph.D., Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2009) 114 (22): 39.
https://doi.org/10.1182/blood.V114.22.39.39
Published: 2009
Journal Articles

Enhanced Jak2 Activation Correlates with β Chain Expression Leading to Phosphorylation of Tyrosine 177 of Bcr-Abl.

Wenjing Tao, Ph.D., Ajoy K. Samanta, Ph.D., Waldemar Priebe, Ph.D., Ralph B. Arlinghaus, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2170.
https://doi.org/10.1182/blood.V114.22.2170.2170
Published: 2009
Journal Articles

Disruption of the Bcr-Abl/Jak2/HSP90 Network Complex Leading to Induction of Apoptosis in Drug-Resistant CML Cells by a New Compound WP1193

Ajoy K. Samanta, PhD, Sandip N. Chakraborty, Susmita Samanta, Ph.D., Yan Wang, M.D., Xiaoping Sun, MD, PhD, E. Schlette, Waldemar Priebe, Ph.D., Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2008) 112 (11): 3199.
https://doi.org/10.1182/blood.V112.11.3199.3199
Published: 2008
Journal Articles

WP-1066, a Next-Generation Member of JAK-Stat Inhibitors, Induces Cell Cycle Arrest, Abrogates Proliferation, and Induces Apoptosis of Acute Myeloid Leukemia (AML) Cells.

Alessandra Ferrajoli, M.D., Stefan Faderl, M.D., Quin Van, B.S., David M. Harris, B.S., Waldemar Priebe, Ph.D., Hagop M. Kantarjian, M.D., Moshe Talpaz, M.D., Zeev Estrov, M.D.
Journal: Blood
Blood (2004) 104 (11): 1169.
https://doi.org/10.1182/blood.V104.11.1169.1169
Published: 2004